<DOC>
	<DOC>NCT02104479</DOC>
	<brief_summary>Diagnostic accuracy of biomarker testing (galactomannan (GM), (1</brief_summary>
	<brief_title>Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing</brief_title>
	<detailed_description>A multicentre, open, prospective diagnostic study on the diagnostic accuracy of biomarker testing (galactomannan (GM), (1</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Invasive Pulmonary Aspergillosis</mesh_term>
	<criteria>prolonged neutropenia &gt; 10 d, patients after allogeneic stem cell transplantation or solid organ transplantation, Patients wth acute leukemia in induction treatment, patients witrh graftversushostdisease, patients under chronic immunusuppressive therapy such as ciclosporin, patients with HIV, patients with chronic steroid treatment Age &lt; 18 years missing informed consent contraindication for pleural centesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>